Hint mode is switched on Switch off

L&G Pharma Breakthrough UCITS ETF (USD) (BIGT, IE00BF0H7608)

(%)
9.04 USD
NAV Per Share
Exchange Traded Funds (ETF)
Type of fund
Equity
Investment category
Healthcare
Sector
Global
Investor locations
23/01/2018
Inception Date
17.5 mln USD
Total assets of the fund
0.49 %
Total Cost Ratio
Solactive Pharma Breakthrough Value
Benchmark
Legal & General Investment Management (LGIM)
Provider
17.51 mln USD
Stock class assets
No
Dividend payments
-
Replication method
-
Minimum entry threshold
-
Split
IE00BF0H7608
ISIN
BIGT
Ticker
CEOGMS
CFI

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Quotes (BIGT)

Yield on 19/04/2024

  • YTD
    -12.75 %
  • 1M
    -5.79 %
  • 3M
    -8.36 %
  • 6M
    -8.6 %
  • 1Y
    -22.5 %
  • 3Y
    -
  • 5Y
    -
  • 10Y
    -
At the price on the exchange, taking into account income payments

Price dynamics

Other ETF & Funds from this provider

Registration is required to get access.